POSTN and lung carcinoma: Periostin promotes tumor progression by interacting with integrin receptors and activating survival pathways.[25,26] In COPD, chronic inflammation upregulates periostin, leading to ECM remodeling that may foster a tumor-promoting microenvironment, bridging COPD and lung cancer risk.